StockData
Harvard Bioscience Inc logo

Harvard Bioscience Inc (HBIO) stock

HBIONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/3013% above fair value
$8.66−0.02 (-0.23%)

Close on Nov 20, 2026Market cap $39.42MP/E –Yield –

Harvard Bioscience free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Harvard Bioscience's free cash flow for the twelve months ending Jun 30, 2026 was -$1.12M, down 123.1% year over year. For fiscal 2025 it was $5.47M. The highest annual figure on record is $12.24M in fiscal 2023.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.47M–
FY2024Dec 31, 2024-$1.20M-109.8%
FY2023Dec 31, 2023$12.24M–
FY2022Dec 31, 2022-$438.00K-753.7%
FY2021Dec 31, 2021$67.00K-99.2%
FY2020Dec 31, 2020$8.18M+19.8%
FY2019Dec 31, 2019$6.83M+259.8%
FY2018Dec 31, 2018$1.90M+1036.5%
FY2017Dec 31, 2017$167.00K–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$363.00K-113.6%
Q1 FY2026Mar 31, 2026-$1.09M-144.0%
Q4 FY2025Dec 31, 2025-$545.00K-138.3%
Q3 FY2025Sep 30, 2025$877.00K–
Q2 FY2025Jun 30, 2025$2.67M–
Q1 FY2025Mar 31, 2025$2.47M+226.3%
Q4 FY2024Dec 31, 2024$1.42M-59.0%
Q3 FY2024Sep 30, 2024-$1.72M-141.6%
Q2 FY2024Jun 30, 2024-$1.66M-154.8%
Q1 FY2024Mar 31, 2024$758.00K-52.3%
Q4 FY2023Dec 31, 2023$3.47M+42.1%
Q3 FY2023Sep 30, 2023$4.14M+1901.9%
Q2 FY2023Jun 30, 2023$3.04M–
Q1 FY2023Mar 31, 2023$1.59M–
Q4 FY2022Dec 31, 2022$2.44M–
Q3 FY2022Sep 30, 2022$207.00K–
Q2 FY2022Jun 30, 2022-$632.00K-212.5%
Q1 FY2022Mar 31, 2022-$2.46M-377.3%
Q4 FY2021Dec 31, 2021-$241.00K-109.9%
Q3 FY2021Sep 30, 2021-$1.14M-210.4%
Q2 FY2021Jun 30, 2021$562.00K-73.1%
Q1 FY2021Mar 31, 2021$886.00K-66.3%
Q4 FY2020Dec 31, 2020$2.43M+36.1%
Q3 FY2020Sep 30, 2020$1.03M-63.1%
Q2 FY2020Jun 30, 2020$2.09M+454.4%
Q1 FY2020Mar 31, 2020$2.63M+40.9%
Q4 FY2019Dec 31, 2019$1.78M-28.7%
Q3 FY2019Sep 30, 2019$2.80M–
Q2 FY2019Jun 30, 2019$377.00K-66.8%
Q1 FY2019Mar 31, 2019$1.87M–
Q4 FY2018Dec 31, 2018$2.50M–
Q3 FY2018Sep 30, 2018-$1.69M-189.4%
Q2 FY2018Jun 30, 2018$1.14M+381.4%
Q1 FY2018Mar 31, 2018-$45.00K–
Q4 FY2017Dec 31, 2017-$1.15M–
Q3 FY2017Sep 30, 2017$1.89M–
Q2 FY2017Jun 30, 2017$236.00K–
Q1 FY2017Mar 31, 2017-$808.00K–

More Harvard Bioscience figures

See a number that looks wrong?